Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1996
05/09/1996WO1996013254A1 Pharmaceutical composition comprising atovaquone
05/09/1996WO1996013252A1 Process for preparing solid pharmaceutical dosage forms
05/09/1996WO1996013249A1 Pharmaceutical compositions
05/09/1996WO1996013247A1 Antiodor, antimicrobial and preservative compositions and methods of using same
05/09/1996WO1996013168A1 Method for treating anxiety
05/09/1996WO1996013167A1 Method for treating anxiety
05/09/1996WO1996013166A1 Method for treating anxiety
05/09/1996WO1996013164A1 Polymeric wound healing accelerators
05/09/1996WO1996010034A3 Thiol-free inhibitors of farnesyl-protein transferase
05/09/1996WO1996008242A3 Clotrimazole metabolites in the treatment of sickle cell disease
05/09/1996DE4447586A1 Use of ionophores to modulate protein tyrosine phosphatase activity
05/09/1996DE4439662A1 Measuring activity of protein:tyrosine:phosphatase in intact cells
05/09/1996DE4439477A1 Use of alpha-liponic acid, its isomers and derivs.
05/09/1996CA2513441A1 Pharmaceutical compositions
05/09/1996CA2204020A1 Nucleic acid transfer system
05/09/1996CA2203920A1 Antiodor, antimicrobial and preservative compositions and methods of using same
05/09/1996CA2203875A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996CA2203814A1 Nitro-benzamides useful as anti-arrhythmic agents
05/09/1996CA2203791A1 Synthetic polyunsaturated fatty acid analogues
05/09/1996CA2203767A1 Protein kinase inhibitors for treatment of neurological disorders
05/09/1996CA2203757A1 Method and compositions for inhibiting protein kinases
05/09/1996CA2203675A1 L-erythrosyl nucleosides
05/09/1996CA2203672A1 L-ribofuranosyl nucleosides
05/09/1996CA2203659A1 Pyridopyrimidones, quinolines and fused n-heterocycles as bradykinin antagonists
05/09/1996CA2203641A1 Bcl-x/bcl-2 associated cell death regulator
05/09/1996CA2203277A1 Oral hypoglycemic agents
05/09/1996CA2202881A1 Stretch-activated cation channel and antisense oligonucleotides thereto
05/09/1996CA2202784A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996CA2202781A1 Method for treating anxiety
05/09/1996CA2202777A1 Method for treating anxiety
05/09/1996CA2202776A1 Method for treating anxiety
05/09/1996CA2202682A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
05/09/1996CA2200886A1 Use of ner receptors potentiators
05/09/1996CA2200468A1 Muscarine antagonists
05/09/1996CA2200462A1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
05/09/1996CA2162223A1 Adhesion receptor antagonists
05/09/1996CA2162089A1 ¬3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy|-pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists
05/09/1996CA2161046A1 Process for large-scale production of bms 180048 and analogs
05/08/1996EP0710689A2 Polymeric antitumor agents
05/08/1996EP0710674A2 Glucan having cyclic structure and method for producing the same
05/08/1996EP0710667A2 Modified oligonucleotides, their preparation and their use
05/08/1996EP0710665A1 Phosphonosulfonate squalene synthetase inhibitor salts and method
05/08/1996EP0710662A1 Quinolinecarboxylic acid derivative
05/08/1996EP0710659A1 Oxazolidinedione derivatives, their production and use
05/08/1996EP0710658A1 5-(Aryloxymethyl)oxazolines, process for their preparation and pharmaceutical compositions containing them
05/08/1996EP0710657A1 Antagonists of adhesion receptors
05/08/1996EP0710653A1 Salts of nefazodone having improved dissolution rates
05/08/1996EP0710646A1 1,5-disubstituted 7a-methylperhydroinden-3a-ol derivatives, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
05/08/1996EP0710486A1 Remedy for urination disorder accompanying prostatic hypertrophy
05/08/1996EP0710485A1 Agents for stimulating hematopoiesis
05/08/1996EP0710484A2 Mixture of alpha-D-glucopyranosyl-(1-6)-glucopyranose as antitumor agent
05/08/1996EP0710483A1 Use of some glycosaminoglycans for the manufacture of a medicament for the treatment of chronic renal failure
05/08/1996EP0710482A2 Therapeutic agent for myocardial ischemic damages or reperfusion injuries
05/08/1996EP0710481A1 Use of flesinoxan for cognition enhancement
05/08/1996EP0710480A1 Pharmaceutical composition comprising L-lactic acid and its use
05/08/1996EP0710288A1 Adenoviral vectors for treatment of hemophilia
05/08/1996EP0710280A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
05/08/1996EP0710248A1 Melanoma-inhibiting protein
05/08/1996EP0710242A1 Antiparasitic agents
05/08/1996EP0710241A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them
05/08/1996EP0710240A1 Novel antimitotic binary alkaloid derivatives extracted from catharanthus roseus
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996EP0710237A1 Quinolizidines with calcium channel antagonistic activity
05/08/1996EP0710236A1 Azalicyclooctane derivatives as anti-arrhythmic agents
05/08/1996EP0710235A1 Endothelin antagonists
05/08/1996EP0710233A1 Heteroaryl cycloalkenyl hydroxyureas
05/08/1996EP0710230A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
05/08/1996EP0710229A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
05/08/1996EP0710227A1 Vitamin d analogues
05/08/1996EP0710123A1 Adenovirus vectors for gene therapy sponsorship
05/08/1996EP0710121A1 Method for treating multiple sclerosis
05/08/1996EP0710116A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
05/08/1996EP0710113A1 Preparation for improving the blood supply containing hard magnetic particles
05/08/1996EP0710112A1 Use of vitamin D and derivatives thereof for the manufacture of a medicament for protection against neuron loss
05/08/1996EP0710111A1 Hormonal agent for the treatment of acne and its use
05/08/1996EP0710110A1 Rapamycin conjugates and antibodies
05/08/1996EP0710109A1 Compounds
05/08/1996EP0710108A1 Liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl)propionic acid
05/08/1996EP0710107A1 N,n,n-trimethylsphingosine derivatives
05/08/1996EP0710106A1 Method of treating addictive behaviors
05/08/1996EP0710105A1 Synergistic anthelmintic compositions
05/08/1996EP0710104A1 Pharmaceutical compositions for hardly soluble active substances
05/08/1996EP0710103A1 Pharmaceutical compositions for hardly soluble active substances
05/08/1996EP0667791A4 Isolation, growth, differentiation and genetic engineering of human muscle cells.
05/08/1996EP0593437B1 Gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
05/08/1996EP0585440B1 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
05/08/1996EP0580648B1 Process for conditioning of water-soluble substances
05/08/1996EP0559898B1 Anilide derivative
05/08/1996EP0517778B1 Vasoactive vasotocin derivatives
05/08/1996EP0472526B1 5-AMINOCARBONYL-5H-DIBENZO a,d]CYCLOHEPTEN-5,10-IMINES FOR TREATMENT OF EPILEPSY AND COCAINE ADDICTION
05/08/1996CN1122138A Foldback triplex-forming oligonucleotides
05/08/1996CN1122136A Benzo|f¨quinoxalindione derivatives, their preparation and their use in drugs
05/08/1996CN1122135A Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
05/08/1996CN1122133A Novel bisoxadiazolidine derivative
05/08/1996CN1122132A Ligands and metal complexes thereof
05/08/1996CN1122109A Veterinary composition containing a proton pump inhibitor
05/08/1996CN1122106A Peritoneal dialysis solutions containing maltodextrins and amino acids
05/08/1996CN1122105A Treatment of tumors with compounds having RXR retinoid receptor agonist activity
05/08/1996CN1122104A Gaba-Ergic modulation of eye growth
05/08/1996CN1121921A New benzothiadiazine compound, process for its preparation and the pharmaceutical compositions which contain it
1 ... 6919 6920 6921 6922 6923 6924 6925 6926 6927 6928 6929 6930 6931 6932 6933 6934 6935 6936 6937 6938 6939 ... 7860